Fluticasone furoate 50mcg, 100mcg, 200mcg; per inhalation; dry pwd for oral inhalation. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for ...

The US Food and Drug Administration (FDA) has approved fluticasone furoate inhalation powder (Arnuity Ellipta, GlaxoSmithKline) as maintenance treatment for asthma in patients aged 12 years and older, ...

GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of ...

Arnuity Ellipta has been approved in doses of 100 mcg and 200 mcg as a once-daily inhaled corticosteroid (ICS.TO) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged ...

Please provide your email address to receive an email when new articles are posted on . GlaxoSmithKline announced that the FDA has approved Arnuity Ellipta, a once-daily inhaled corticosteroid, for ...

New Inhalers for Asthma, COPD Launched by GSK GlaxoSmithKline announced the launch of Arnuity Ellipta (fluticasone furoate inhalation powder) and Incruse Ellipta (umeclidinium bromide inhalation ...

GlaxoSmithKline’s inhaled corticosteroid Arnuity Ellipta has been approved in the US for paediatric use. GlaxoSmithKline’s inhaled corticosteroid Arnuity Ellipta has been approved in the US for ...

GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for ...

GlaxoSmithKline ( GSK) received positive news when the FDA approved its asthma treatment, Arnuity Ellipta. Arnuity Ellipta has been approved in doses of 100 mcg and 200 mcg as a once-daily inhaled ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ARNUITY ELLIPTA contains the active ingredient fluticasone furoate.